Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05148689 · ClinicalTrials.gov registry record · Phase 1
A Study Comparing Oxymetazoline 1% Cream to RHOFADE
A Phase 1 study, sponsored by Sun Pharmaceutical Industries.
- Completed
- Registry status
- Phase 1
- Development phase
- 82
- Enrollment target
NCT05148689 is a Phase 1 study that has completed, run by Sun Pharmaceutical Industries. The registered enrollment target is 82 participants.
The verdict
NCT05148689, a Phase 1 study, has completed, sponsored by Sun Pharmaceutical Industries.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 82 participants
- Enrollment target
Study Summary
randomized, double-blind, placebo controlled
Interventions
- DRUG Placebo
- DRUG Oxymetazoline hydrochloride Cream, 1%
- DRUG Rhofade™ (oxymetazoline) cream, 1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2018-02-23 |
| Est. Completion | 2019-05-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05148689
The ClinicalTrials.gov registry entry for NCT05148689 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sun Pharmaceutical Industries, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT05148689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05148689 about?
NCT05148689 is a clinical study titled "A Study Comparing Oxymetazoline 1% Cream to RHOFADE". randomized, double-blind, placebo controlled
What is the current status of trial NCT05148689?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 82 participants. The study started on 2018-02-23. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT05148689?
The interventions under investigation include: Placebo (DRUG), Oxymetazoline hydrochloride Cream, 1% (DRUG), Rhofade™ (oxymetazoline) cream, 1% (DRUG).
Who is sponsoring clinical trial NCT05148689?
This trial is sponsored by Sun Pharmaceutical Industries, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.